A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...

(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...

First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3KdThe European Medicines Agency (EMA) has granted Orphan Drug Designation for roginolisib for treatment ...

Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards ...

The EU lacks cohesive governance to deploy economic statecraft tools, such as sanctions and export controls, undermining ...

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...

Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.

The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...